Retraction Statement: Inhibition of miR‐499‐5p expression improves nonalcoholic fatty liver disease
Authors:
Open Access
- 20 January 2020
- journal article
- retracted article
- Published by Wiley in Annals of Human Genetics
- Vol. 86 (6) , 369
Abstract
Objective Nonalcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver diseases. However, the pathogenesis of NAFLD is largely unknown. Here, we investigated the specific role of miR‐499‐5p in NAFLD. Methods Free fatty acid was used to induce HL‐7702 cell line to establish a NAFLD cell model, and animal models of NAFLD were constructed by feeding C57BL/6 mice with a high‐fat diet. Expression levels of miR‐499‐5p in the HL‐7702 cells and C57BL/6 mice were determined by quantitative real‐time polymerase chain reaction. In addition, functional experiments were carried out through transfecting miR‐499‐5p inhibitor into NAFLD cells, and injecting NAFLD mice with a lentiviral vector with the miR‐499‐5p inhibitor. Furthermore, the effects of miR‐499‐5p on lipidation and inflammation were investigated by oil red O staining, hematoxylin–eosin staining, and biochemical analysis. Results Compared with normal controls, the expression of miR‐499‐5p was significantly up‐regulated in NAFLD cells and tissues in mouse. After NAFLD cells transfected by miR‐499‐5p inhibitor, the expression of miR‐499‐5p was inhibited, the lipid deposition and content of triglycerides (TGs) were reduced, and the lipidation was improved. Simultaneously, after NAFLD mice were injected with the miR‐499‐5p lentiviral vector, the degree of lipid droplet deposition and content of TGs were also reduced. In addition, it decreased the levels of total cholesterol and aspartate aminotransferase in serum, and improved hepatic lipid metabolism. Conclusions Inhibition of miR‐499‐5p expression improved NAFLD in mice, which provided a new direction for the treatment of NAFLD.Keywords
All Related Versions
This publication has 33 references indexed in Scilit:
- miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCRInternational Journal of Molecular Medicine, 2015
- Identification of miR-423 and miR-499 Polymorphisms on Affecting the Risk of Hepatocellular Carcinoma in a Large-Scale PopulationGenetic Testing and Molecular Biomarkers, 2014
- New mechanisms contributing to hepatic steatosis: glucose, insulin, and lipid signalingAnimal Cells and Systems, 2014
- The Lipid Droplet as a Potential Therapeutic Target in NAFLDSeminars in Liver Disease, 2013
- Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liverClinica Chimica Acta, 2013
- Betaine Protects Against High-Fat-Diet-Induced Liver Injury by Inhibition of High-Mobility Group Box 1 and Toll-Like Receptor 4 Expression in RatsDigestive Diseases and Sciences, 2013
- Transition from hepatic steatosis to steatohepatitis: Unique microRNA patterns and potential downstream functions and pathwaysJournal of Gastroenterology and Hepatology, 2011
- MicroRNAs in Development and DiseasePhysiological Reviews, 2011
- Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008